Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American journal of ophthalmology-glaucoma

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AJO.2006.02.047PMID 16815265PMCID PMC3960010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.

  2005cited by this paper
• Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.

  2004cited by this paper
• Elephantiasic Pretibial Myxedema

  2004cited by this paper
• Infections and anti-tumor necrosis factor alpha therapy.

  2003cited by this paper
• Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway1

  2003cited by this paper
• Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.

  2003cited by this paper
• Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?

  2003cited by this paper
• Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.

  2003cited by this paper
• Impact of smoking on the response to treatment of thyroid associated ophthalmopathy

  2003cited by this paper
• Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.

  2003cited by this paper
• Infections and anti–tumor necrosis factor α therapy

  2003cited by this paper
• Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo.

  2003cited by this paper
• TSH‐R expression and cytokine profile in orbital tissue of active vs. inactive Graves’ ophthalmopathy patients

  2003cited by this paper
• Graves' Dermopathy and Acropachy Are Markers of Severe Graves' Ophthalmopathy

  2003cited by this paper
• Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.

  2002cited by this paper
• Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

  2002cited by this paper
• Igs from Patients with Graves’ Disease Induce the Expression of T Cell Chemoattractants in Their Fibroblasts1

  2002cited by this paper
• Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.

  2002cited by this paper
• Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts

  2002cited by this paper
• Elephantiasic Pretibial Myxedema: Insight into and a Hypothesis Regarding the Pathogenesis of the Extrathyroidal Manifestations of Graves' Disease

  2000cited by this paper
• Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy

  2000cited by this paper
• Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.

  1999cited by this paper
• Development of an animal model of autoimmune thyroid eye disease.

  1999cited by this paper
• Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.

  1998cited by this paper
• Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production.

  1998cited by this paper
• Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

  1998cited by this paper
• Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.

  1997cited by this paper
• Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

  1997cited by this paper
• Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy.

  1997cited by this paper
• Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts.

  1995cited by this paper
• Pathogenesis of Graves' ophthalmopathy.

  1993cited by this paper
• Smoking and risk of Graves' disease.

  1993cited by this paper
• Detection of TSH Receptor RNA in Cultured Fibroblasts from Patients with Graves' Ophthalmopathy and Pretibial Dermopathy

  1993cited by this paper
• Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue.

  1993cited by this paper
• More on smoking habits and Graves’ ophthalmopathy

  1989cited by this paper
• Regulation of lipolysis during the neonatal period. Importance of thyrotropin.

  1988cited by this paper
• Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease.

  1986cited by this paper
• Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis.

  1986cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Thyrotropin Receptor Expression in Graves ’ Orbital Adipose/Connective Tissues: Potential Autoantigen in

  year unknowncited by this paper

• Changes in corneal and lenticular transparency in active and inactive Graves' Ophthalmopathy: a comparative densitometric study

  2026cites this paper
• Rapid multiparametric quantitative MRI for predicting the activity of thyroid-associated ophthalmopathy: combination with clinical characteristics

  2025cites this paper
• Predictive demographic and clinical features for the development of dysthyroid optic neuropathy in a multi-ethnic TED population: a retrospective cohort study

  2025cites this paper
• Radiological Activity Score (RAS)—MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi‐Ethnic Thyroid Eye Disease Population

  2025cites this paper
• Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review

  2025cites this paper
• The Use of Biologics for Thyroid Eye Disease

  2025cites this paper
• Research Progress of the PI3K/AKT Signaling Pathway in Ophthalmic Diseases

  2025cites this paper
• Efficacy and safety of botulinum toxin as a non-surgical option for upper eyelid retraction in active thyroid-associated ophthalmopathy: a prospective interventional study

  2025cites this paper
• Effect of enalapril and losartan on the expression of genes involved in inflammation, fibrogenesis, and apoptosis in orbital fibroblasts of graves’ ophthalmopathy

  2025cites this paper
• Ocular Neuromyotonia in Thyroid Eye Disease

  2025cites this paper
• Tear Inflammatory Cytokine Profiles in Thyroid-Associated Ophthalmopathy.

  2025cites this paper
• A Lady with Unilateral Painful Orbital Swelling with Possible Euthyroid Graves Ophthalmopathy

  2025cites this paper
• The role of Tenascin-X, Paraoxonase 1 and some other biochemical parameters in infertility women

  2024cites this paper
• GSDMD mediated pyroptosis induced inflammation of Graves' orbitopathy via the NF-κB/ AIM2/ Caspase-1 pathway.

  2024cites this paper
• Teprotumumab for Thyroid Eye Disease-related Strabismus

  2024cites this paper
• Role of Inositol-Requiring Enzyme 1 and Autophagy in the Pro-Fibrotic Mechanism Underlying Graves’ Orbitopathy

  2024cites this paper
• Morphometric analysis of extraocular muscles and proptosis by computed tomography in Graves’ orbitopathy

  2024cites this paper
• The changing landscape of thyroid eye disease: current clinical advances and future outlook

  2024cites this paper
• Análise morfométrica da musculatura ocular extrínseca e da proptose por tomografia computadorizada na orbitopatia de Graves

  2024cites this paper
• Chronic Lymphocytic Leukemia Producing Infiltrative Orbitopathy Masquerading as Thyroid Eye Disease.

  2024cites this paper
• Порівняльний аналіз волюмометричних характеристик м’якотканинного вмісту орбіти у пацієнтів з ендокринною орбітопатією методами комп’ютерного моделювання

  2024cites this paper
• Synergistic Therapy for Graves’ Ophthalmopathy-Associated Eyelid Retraction: Steroid, 5-FU, and Botulinum Neurotoxin a Combination

  2024cites this paper
• Long-Term Follow-Up of a Case of Severe Hyperglycemia Requiring Hospitalization after Third Dose of Teprotumumab: A Case Report

  2024cites this paper
• Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease

  2023cites this paper
• The Effect of Rho Kinase Inhibitors on In Vitro Human Orbital Preadipocytes

  2023cites this paper
• Evaluation of corneal endothelium and correlation with disease severity in patients with Graves' ophthalmopathy: A specular microscopy-based study.

  2023cites this paper
• Update on the surgical management of Graves’ orbitopathy

  2023cites this paper
• Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease

  2023cites this paper
• Reduction in Extraocular Muscle Cross-sectional Area and Correlation With Extraocular Motility and Diplopia Following Teprotumumab for Thyroid Eye Disease

  2023cites this paper
• An evaluation of corneal endothelial cell morphology in patients with thyroid-associated ophthalmopathy

  2023cites this paper
• Hyperglobus and Pseudoptosis in Type 1 Lipogenic Thyroid Eye Disease

  2023cites this paper
• Differentially expressed genes in orbital adipose/connective tissue of thyroid-associated orbitopathy

  2023cites this paper
• Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy

  2023cites this paper
• A Case of Third Cranial Nerve Palsy Accompanying Thyroid Eye Disease

  2023cites this paper
• The Changes in Ocular Biomechanical Response Parameters and Intraocular Pressure After Surgical Treatment for Thyroid Eye Disease

  2023cites this paper
• Choroidal thickness in thyroid eye disease and its correlation with disease activity

  2023influential citation
• Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET

  2023cites this paper
• Neoteric Role Of Quercetin In Visual Disorders.

  2023cites this paper
• Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts

  2022cites this paper
• Therapeutic Potential of Targeting Periostin in the Treatment of Graves’ Orbitopathy

  2022cites this paper
• Tears as a Source of Biomarkers in the Diagnosis of Graves’ Orbitopathy

  2022cites this paper
• Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy

  2022cites this paper
• Long-term follow-up of surgical treatment of thyroid-associated orbitopathy restrictive strabismus

  2022cites this paper
• Optic disc, macula and ganglion cell layer measurements obtained with optical coherence tomography in patients with thyroid disorder

  2022cites this paper
• Role of orbital magnetic resonance imaging in early detection of graves’ orbitopathy and disease activity

  2022cites this paper
• HAIR SCIENCE MINI-SERIES: Neuroendocrinology of the Human Hair Follicle Episode 3: A “Hairy” Excursion into the Hypothalamic-Pituitary-Thyroid Axis

  2021cites this paper
• Absent Bell’s phenomenon in patients with thyroid eye disease

  2021cites this paper
• Ganglioside GT1b increases hyaluronic acid synthase 2 via PI3K activation with TLR2 dependence in orbital fibroblasts from thyroid eye disease patients

  2021cites this paper
• De Novo Extra-Thyroidal Manifestations of Graves’ Disease presenting 16 Years after Total Thyroidectomy for Thyroid Cancer

  2021cites this paper
• Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.

  2021cites this paper
• Orbital myositis: A diagnostic challenge

  2021cites this paper
• Fibroblast function in COVID-19

  2021cites this paper
• Anti-inflammatory and Antioxidant Effects of Selenium on Orbital Fibroblasts of Patients With Graves Ophthalmopathy

  2021cites this paper
• Proteomics of Tear in Inactive Thyroid-Associated Ophthalmopathy.

  2021cites this paper
• The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves’ Ophthalmopathy

  2021cites this paper
• PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis.

  2021cites this paper
• Neferine suppresses autophagy‐induced inflammation, oxidative stress and adipocyte differentiation in Graves' orbitopathy

  2021cites this paper
• Application of electrophysiological tests in the evaluation of early thyroid-associated ophthalmopathy

  2021cites this paper
• Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves’ orbitopathy

  2021cites this paper
• Fibroblast function in COVID-19

  2021cites this paper
• Risk factors for Graves' Orbitopathy in surgical patients—Results of a 10‐year retrospective study with review of the literature

  2020cites this paper
• Integrating Differential Gene Expression Analysis with Perturbagen-Response Signatures May Identify Novel Therapies for Thyroid-Associated Orbitopathy

  2020cites this paper
• The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy

  2020cites this paper
• Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease

  2020cites this paper
• Reduced macular inner retinal thickness and microvascular density in the early stage of patients with dysthyroid optic neuropathy

  2020cites this paper
• Protein tyrosine phosphatase 1B as a therapeutic target for Graves’ orbitopathy in an in vitro model

  2020cites this paper
• Characterization of a Murine Model of Oxazolone-Induced Orbital Inflammation

  2020cites this paper
• Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping To Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.

  2020cites this paper
• Fucoxanthin improves functional recovery of orbitopathy in Graves’ disease by downregulating IL-17 mRNA expression in a mouse model

  2020cites this paper
• Orbital myositis: a diagnostic challenge.

  2020cites this paper
• In Vivo Confocal Microscopy Morphometric Analysis of Meibomian Glands in Patients With Graves Ophthalmopathy.

  2020cites this paper
• Medical treatment in thyroid eye disease in 2020

  2020cites this paper
• Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy

  2020cites this paper
• Analysis of Foveal and Parafoveal Microvascular Density and Retinal Vessel Caliber Alteration in Inactive Graves' Ophthalmopathy

  2020cites this paper
• Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking

  2020cites this paper
• Thyroid eye disease presenting with superior rectus/levator complex enlargement

  2020cites this paper
• Thyroid hormones and tendon: current views and future perspectives.

  2019cites this paper
• A nomenclature to describe the sequence of visual field defects in progressive thyroid eye disease compressive optic neuropathy.

  2019cites this paper
• Clinical outcomes of graves ophthalmopathy

  2019cites this paper
• Immunological Aspects of Graves' Ophthalmopathy

  2019cites this paper
• Exophthalmos and multinodular goitre, an unusual combination

  2019cites this paper
• A Pathway Analysis Based on Genome-Wide DNA Methylation of Chinese Patients with Graves' Orbitopathy

  2019cites this paper
• Value of Infrared Thermography Camera Attached to a Smartphone for Evaluation and Follow-up of Patients with Graves' Ophthalmopathy

  2019cites this paper
• Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy

  2019cites this paper
• Therapeutic Effect of Curcumin, a Plant Polyphenol Extracted From Curcuma longae, in Fibroblasts From Patients With Graves' Orbitopathy.

  2019cites this paper
• Effect of orbital decompression on dysthyroid optic neuropathy

  2019cites this paper
• Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ Orbitopathy

  2019cites this paper
• Tiroid Fonksiyon Bozukluğunda Uygulanan Antitiroid Tedavinin Oküler Yüzey Üzerine Etkisi

  2019cites this paper
• Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues

  2019cites this paper
• Oxidative stress markers in tears of patients with Graves’ orbitopathy and their correlation with clinical activity score

  2018cites this paper
• Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy

  2018cites this paper
• A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves’ orbitopathy

  2018cites this paper
• Measurement of Orbital Biomechanical Properties in Patients with Thyroid Orbitopathy Using the Dynamic Scheimpflug Analyzer (Corvis ST)

  2018cites this paper
• The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy

  2018cites this paper
• Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves’ orbitopathy

  2018cites this paper
• Décompression endoscopique endonasale du nerf optique et de l’apex orbitaire dans la neuropathie optique dysthyroïdienne réfractaire : étude prospective de 23 décompressions

  2018influential citation
• Changes of Nicotinamide Phosphoribosyltransferase Expressions in Thyroid Glands of Patients with Different Thyroid Pathologies

  2018cites this paper
• Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma

  2018cites this paper
• Corneal biomechanical properties in patients with Hashimoto's thyroiditis.

  2018cites this paper
• Thyroid Orbitopathy.

  2018cites this paper